Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

The spectrum of somatic mutation of the most aggressive forms of neuroblastoma is not completely determined. We sought to identify potential cancer drivers in clinically aggressive neuroblastoma. Whole exome sequencing was conducted on 17 germline and tumor DNA samples from high-risk patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasorsa, Vito Alessandro, Formicola, Daniela, Pignataro, Piero, Cimmino, Flora, Calabrese, Francesco Maria, Mora, Jaume, Esposito, Maria Rosaria, Pantile, Marcella, Zanon, Carlo, De Mariano, Marilena, Longo, Luca, Hogarty, Michael D., de Torres, Carmen, Tonini, Gian Paolo, Iolascon, Achille, Capasso, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008327/
https://www.ncbi.nlm.nih.gov/pubmed/27009842
http://dx.doi.org/10.18632/oncotarget.8187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008327/
https://www.ncbi.nlm.nih.gov/pubmed/27009842
http://dx.doi.org/10.18632/oncotarget.8187

Ejemplares similares